Literature DB >> 19325052

Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation.

Angela D Levy1, Janet C Shaw, Leslie H Sobin.   

Abstract

Tumors and tumorlike lesions that secondarily involve the mesothelial or submesothelial layers of the peritoneum are a diverse group of disorders that range in biologic behavior from benign to highly malignant. The anatomy of peritoneal ligaments and mesenteries and the normal circulation of peritoneal fluid dictate location and distribution of these diseases within the peritoneal cavity. Peritoneal carcinomatosis is the most common secondary tumor to affect the peritoneal cavity. When it arises from carcinomas of the gastrointestinal tract or ovary, the prognosis is grave. However, when low-grade mucinous adenocarcinoma of the appendix spreads to the peritoneal cavity, the consequence is typically pseudomyxoma peritonei, which is a clinical syndrome, characterized by recurrent and recalcitrant voluminous mucinous ascites due to surface growth on the peritoneum without significant invasion of underlying tissues. Carcinomas from elsewhere in the body, as well as lymphomas and sarcomas, may also produce diffuse peritoneal metastasis. Granulomatous peritonitis is the consequence of disseminated infection such as tuberculosis or histoplasmosis, foreign materials, or rupture of a tumor or hollow viscus. Finally, a group of benign miscellaneous conditions that range from common disorders such as endometriosis and splenosis to very rare conditions such as gliomatosis peritonei and melanosis may also affect the peritoneum diffusely. Secondary tumors and tumorlike lesions of the peritoneum have overlapping imaging features when compared with each other and primary peritoneal tumors. Knowledge of peritoneal anatomy, normal fluid circulation within the peritoneal cavity, and clinical and pathologic features of secondary peritoneal lesions is essential for identification of these lesions.

Entities:  

Mesh:

Year:  2009        PMID: 19325052     DOI: 10.1148/rg.292085189

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  51 in total

1.  Peritoneal sarcoidosis: the role of imaging in diagnosis.

Authors:  Meghan G Lubner; Perry J Pickhardt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2009-12

2.  Infliximab for the treatment of granulomatous peritonitis.

Authors:  Ann Ming Yeh; John Kerner; Paula Hillard; Dorsey Bass
Journal:  Dig Dis Sci       Date:  2013-07-02       Impact factor: 3.199

3.  Sclerosing encapsulating peritonitis (cocoon bowel) presenting after laparotomy for splenic abscess.

Authors:  Jason Caldwell; Andrew Dyer
Journal:  J Radiol Case Rep       Date:  2013-10-01

4.  Peritoneal Carcinomatosis Arising from Primary Anorectal Melanoma.

Authors:  Michelle McBride; Sean Calhoun
Journal:  J Radiol Case Rep       Date:  2019-04-30

Review 5.  Imaging ovarian cancer and peritoneal metastases--current and emerging techniques.

Authors:  Stavroula Kyriazi; Stan B Kaye; Nandita M deSouza
Journal:  Nat Rev Clin Oncol       Date:  2010-04-13       Impact factor: 66.675

6.  Radiologic findings of urachal mucinous cystadenocarcinoma causing pseudomyxoma peritonei.

Authors:  Mahmut Kebapçı; Suzan Saylısoy; Cavit Can; Emine Dündar
Journal:  Jpn J Radiol       Date:  2012-01-13       Impact factor: 2.374

7.  Role of Imaging in Peritoneal Surface Malignancies.

Authors:  Santosh Krishnamurthy; Raghav Balasubramaniam
Journal:  Indian J Surg Oncol       Date:  2016-06-08

8.  Differentiation of intra-abdominal desmoid tumor from peritoneal seeding based on CT and/or 18F-FDG PET-CT in patients with history of cancer surgery.

Authors:  June Suh; Hyo-Jin Kang; Se Hyung Kim
Journal:  Abdom Radiol (NY)       Date:  2020-06-19

9.  A Torted Ruptured Intra-abdominal Testicular Seminoma Presenting As An Acute Abdomen.

Authors:  Oliver James Nickalls; Char Loo Tan; Yee Liang Thian
Journal:  J Radiol Case Rep       Date:  2015-12-31

10.  Extensive peritoneal carcinomatosis secondary to renal cell carcinoma with sarcomatoid and rhabdoid differentiation.

Authors:  Ashwini K Esnakula; Tammey J Naab; William Green; Babak Shokrani
Journal:  BMJ Case Rep       Date:  2013-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.